Shenzhen YHLO Biotech Co Ltd

688575

Company Profile

  • Business description

    Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.

  • Contact

    Baolong 2nd Road, Baolong Street
    Building 1, Yahuilong Biotechnology Factory Area
    Longgang District
    Guangdong Province
    Shenzhen518116
    CHN

    T: +86 75584821649

    https://www.szyhlo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,664

Stocks News & Analysis

stocks

Chart of the Week: BHP’s valuation hits historic levels

BHP and peers are trading as if the copper boom is here to stay.
stocks

3 cheap wide moat growth stocks

4 and 5 star companies that can protect and grow their earnings.
stocks

ASX biotech expands diagnostics portfolio after FDA approval

FDA nod adds another growth driver for ASX share.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,908.8034.300.39%
CAC 408,140.5950.310.62%
DAX 4025,537.75135.470.53%
Dow JONES (US)51,461.90631.21-1.21%
FTSE 10010,688.4730.340.28%
HKSE24,476.28237.50-0.96%
NASDAQ25,978.433.14-0.01%
Nikkei 22563,966.8743.870.07%
NZX 50 Index13,735.73113.010.83%
S&P 5007,551.8133.92-0.45%
S&P/ASX 2008,730.3033.800.39%
SSE Composite Index3,880.8510.75-0.28%

Market Movers